Precision Medicine Market
By Delivery Type (On Premise, Off Premise),
By Application (CNS, Oncology, Immunology, Respiratory, Rare Diseases, and Others),
By Administration (Oral, Injectable),
By End Use (Healthcare Suppliers and Diagnostic Suppliers, Academic Bodies and Research Centers, Pharma, and Biotechnology Companies and Others),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):
Precision Medicine Market - Global Analysis and Forecast 2023-2033
The global precision medicine market showcased a revenue of USD 57.77 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 11% over the forecast period of 2023-2033.
Russia-Ukraine War Impact
Market Scope
About the Market
Impact of COVID-19
Global Economic Slowdown
Market Dynamics
Driver
Restrain
Opportunity
Recent Developments
Synopsis
How is this report helpful
FAQ's
Report Coverage
Related Reports
Precision medicine is the approach to define a personalized treatment for an individual depending upon the variability in genetics, environment, or lifestyle. The Genetics of each individual has variability, as do their environment and lifestyle. Precision medicine uses technology to identify these differences and define a suitable treatment tailored to the end patient. Rising utilization in Oncology, rare genetic diseases, and gene therapy is the primary factor driving the market growth for Precision Medicine.
Precision medicine is a newly emerging field that promises so much market growth in terms of research, technological use, and cancer treatments. Precision Medicine uses technology such as gene sequencing, Big data analytics, or Bioinformatics to identify differences in genetic makeup, environment, or lifestyle and thus select the best suitable treatment for further improvisation. Gene sequencing is increasingly used in genetic diseases, oncology, and gene therapy, propelling the market growth of Precision medicine. Gene sequencing predicts the mutations or variability present in an individual's genome so that it can be further corrected using gene therapy. The oncological transformation of cells, or healthy cells into cancerous cells, is a genetic process. Transformed genes can be identified through gene sequencing, and suitable treatment can be applied. Bioinformatics is involved in public health to identify environmental or lifestyle variability. Big data analytics is also applied to analyze, interpret and make sense of a pool of genetic or public health data. AI is also finding application in the predictive modeling of disease states so that earlier predictions of therapy and suitable changes in treatment choices can be made. The rising integration of technologies, as mentioned above, and their application to derive personalized treatment would further add to the market growth of precision medicine.
Furthermore, Precision medicine is also being increasingly studied for other non-communicable diseases. For instance, scientists from the University of Genova and the University of Texas collectively studied the utilization of precision medicine to treat epilepsy. The study highlights the variability in individual response to a common anti-epilepsy therapy and, thus, the role of precision medicine in countering the limitation. Another study by The Chinese University of Hong Kong highlighted the utilization of precision medicine for diabetes management. The study report stated that uniform treatment is associated with diabetic complications. These complications can be handled by genetic information about the individual patient, and thus, precision medicine can be of significant aid for diabetes.
Impact of Russia-Ukraine war on Precision Medicine Market
The Russia-Ukraine war disrupted the precision medicine market within the European region. Shift in fund allocation towards war, followed by acquisition of defence equipment resulted in limited fund allocation towards research and development of precision medicine. Furthermore, the supp;y chain disruption due to the war has created lack of materials and chemicals required to effectively manufacture precision medicines. The lack in funds, followed by lack of materials and steep inflation in the European economies has impacted the growth of precision medicines in a negative manner.
Precision Medicine: Market Scope
The Precision medicine market is primarily divided into four segments Delivery type, Application, Administration, and end-use. Furthermore, these segments are subdivided into respective categories and cross-referenced to North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa for regional analysis. The delivery type segment is further categorized into On-Premise and Off-Premise. The Application segment is segregated into CNS, Oncology, Immunology, Respiratory, Rare Diseases, and Others. Orals or injectables bifurcate the administration segment of the precision medicine market. With respect to end users, the industry is analyzed by Healthcare Suppliers and Diagnostic Suppliers, Academic Bodies and Research Centers, Pharma and Biotechnology Companies, and Others. Each of these segments is further classified into regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The historical dataset of 2018-2022 is provided in the report, whereas the forecast period of 2023-2033 is offered.
Off-premise, the segment will witness the highest growth rate between 2023-2033
Off-premise, medicine delivery would witness the highest growth owing to the fact that treatment delivered would be focused on individual's needs and not on evidence collected from generalized population studies. This is simply equivalent to saying that what suits a population might still not suit an individual based on differences in genetic makeup. End-tailored delivery would be further boosted by the integration of AI, propelling more market growth for off-premise medicine delivery. Off-premise delivery utilizes a patient's genetic data to describe the best suitable treatment and thus predict suitable targeted therapy using AI. Predictive Modelling through AI is also used to predict the therapy response, thus providing helpful insights for off-premise precision medicine.
CNS will capture the highest market share within the Application type segment
Cancer biology and treatment have been made significantly advanced through the integration of precision medicine. However, Central nervous system (CNS) associated disorders are to receive the most attention from this approach. Precision medicine is being studied for Diabetes, Cardiology, and epilepsy. CNS application for epilepsy is most likely to get a boost owing to more frequent instances of variable response among Epilepsy patients. Uniform treatment applied to all CNS patients has been unhelpful owing to high variability within treatment responses. Various scientists are actively studying precision medicine for ADHD disorder. Another study focused on Alzheimer's disease focuses on Precision medicine as an effective strategy. These researches and their application indicate a market growth for precision medicine in CNS disorders.
Oral administration will capture the highest market share in the coming years
Oral tablets and capsules are preferred owing to their better shelf-life and integrity. Most Cancer therapies utilize chemotherapeutics medicine to treat the oncologic cells. Diabetes, Cardiovascular disorders, or CNS disorders are also treated mostly using oral medicines. Precision medicine would utilize data and genetic information to conclude the best possible treatment option, and mostly, a choice of oral medicines is made. In the case of tailored- treatment, precision diagnosis can even push the drug designing of novel drugs meant for targeted action. Oral drug deliveries can also provide a desirable absorption rate as compared to injectable delivery, where the drug is immediately distributed within Blood. Oral preparations release drugs at rates desirable to therapy requirements, thus gaining more preference.
Healthcare Suppliers and Diagnostic Suppliers would capture the highest market share.
Precision medicine is usually an amalgam of various steps and procedures, requiring various tools and equipment to carry out diagnosis, prognosis, and treatment. It includes applying suitable technology to identify and assess the individual's genetic differences. This might be done using next-generation sequencing, Big Data analytics, or Bioinformatics. AI is also applied at certain levels to predict the outcome of treatment and thus correctly asses the treatment procedures suitable to the patient. With so many technological tools requirements, Diagnostic or Healthcare suppliers are expected to witness a considerable rise in forecasted years. In precision medicine, computers, software, and other medical devices would be considerably utilized to apply technology and carry out diagnoses. These requirements propel the market growth for this segment.
North America to capture the highest market share in Precision Medicine Market
Precision medicine largely depends on the technology used to identify genetic differences and thus diagnose. Most technological advancements are made available in the North American region, making this a hotspot for further market growth. North America has progressed with advancements in cancer treatments by developing and applying technology that successfully identifies genes responsible for the oncological transformation of healthy cells, turning them into cancerous cells. The genetic identification is then followed by treatment to correct or cure the genetic fault. It has also moved forward with research carried out on non-communicable diseases such as diabetes, cardiovascular diseases, and others to see if precision medicine can be effectively applied to these disease states. Growing advancements and researches are likely to boost market growth for this region.
Impact of COVID-19 on Precision Medicine Industry
COVID-19 gave a reality check on the fact that genetic variability coupled with environmental and lifestyle differences can largely influence an individual's response to a particular disease. Immunity differences among infected patients were a huge reflection of the same fact. Some individuals recovered quickly owing to stronger immunity, while others took a long while to recover owing to weaker immunity. Immunity is largely dependent on lifestyle and environment, creating so much variability among infected patients' responses. This triggered the further validation and effectiveness of precision medicine. Identification of genetic differences can provide deeper insights as to why a certain disease response was developed in the first place, giving further insights into treating it using a suitable personalized therapy regimen. COVID-19 severity was also assessed using the study of environmental exposures. More hostile environments were likely to produce more infections as compared to less hostile environments. Precision medicine gained enough confidence through COVID-19 and opened up a new market horizon for personalized therapies.
Precision Medicine: Market Dynamics
The market dynamics section of the report covers an in-depth analysis of drivers, restraints, and opportunities impacting the Precision Medicine market. The report also encompasses major market strategies practiced by the industry, followed by patent analysis, product analysis, competitive benchmarking of companies, PORTER and PESTLE analysis of the Precision Medicine industry, pricing analysis, and geographic competitiveness to provide a detailed understanding. The major players operating in the market are AstraZeneca, Bristol-Myers Squibb, Biocrates Life Sciences, Eagle Genomics, Eli Lilly And Company, F. Hoffmann-La Roche AG, Novartis, Pfizer, Quest Diagnostics, and Teva Pharmaceutical. These companies cumulatively hold the majority of Precision Medicine's market share and actively undergo strategic development, such as new product launches, mergers, collaborations, business expansions, acquisitions, and long-term contracts to ensure market penetration. These companies also largely focus on research and development to gain technological competitiveness in the market. A detailed analysis of these companies is offered in the report.
Driver: Technological Advancements in Curing Cancer, Biology and Genetic Diseases
The scope for precision medicine is increasing within cancer biology since oncology largely depends on an individual's genetics. Precision medicine has led to more targeted therapies in cancer patients. Better therapy outcomes can be availed using the integration of artificial intelligence for predictive modeling. These advancements are likely to drive more market growth for precision medicine.
Restrain: Limited Global Penetration of Precision Medicines
Precision medicine is a newly emerging field that requires increasing penetration to be available in every region. Technological advancements need to be cost-effective for adaptability within various regions. Developing and emerging economies will likely adopt precision medicine in the forecasted years. However, the cost can be a restrain in technology transfer. AI or Bioinformatics is not as evolved in other regions as in North America, further restraining the full utilization of precision medicine.
Opportunity: Increasing Applicability to Non-Communicable Diseases
Precision medicine is yet useful for Cancer treatments and genetic therapies. However, research and studies also indicate a growing utilization of Precision medicine for other non-communicable disease states. The China Hong Kong University studied precision medicine for diabetes management. A similar study is done on cardiology, epilepsy, and CNS disorders by other scientists. All these studies indicate a growing potential for precision medicine to be applied in these disease states. This shows a growing market opportunity with increased application.
Precision Medicine Market: Recent Developments
- The National Human Genome Research Institute established a novel method for reliably tracing genomic variations back to hereditary illnesses in January 2023. A genotype-first approach to patient care entails selecting patients with specific genomic variants and then studying their traits and symptoms; this discovery revealed new relationships between genes and clinical conditions, expanded the characteristics and symptoms associated with known disorders, and provided insights into newly described diseases.
- Precision diagnosis was used by the University of Washington School of Medicine/UW Medicine to discover that therapy of childhood-onset hearing loss can be more accurately tailored with information on the individual genetic causes. Understanding of the many diverse genetic causes of childhood-onset hearing loss suggests that genomic testing could aid in individualising treatment strategy.
- Children's Research Hospital of St. Jude Scientists conducted the most comprehensive analysis to date on medication sensitivity in paediatric acute lymphoblastic leukaemia across genetic subtypes and its relationship to treatment response. They discovered that childhood leukaemia pharmacotyping gives a template for 'real precision medicine.'
Precision Medicine Market: Synopsis
The study of the precision medicine market offers revenue and growth data sets of segments provided at the global, regional, and country levels. The report shows the historical data set for 2018-2022 and the forecast period of 2023-2033. For the purpose of analysis, Quadrant Market Insights (QMI) has segregated the Precision Medicine market into four major segments as follows:
By Delivery Type
- On-Premise
- Off-Premise
By Application
- CNS
- Oncology
- Immunology
- Respiratory
- Rare Diseases
- Others
By Administration
- Oral
- Injectable
By End Use
- Healthcare Suppliers and Diagnostic Suppliers
- Academic Bodies and Research Centres
- Pharma and Biotechnology Companies
- Others
The regional analysis of the precision medicine market is as follows:
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Russia
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Israel
Key players operating in the precision medicine industry are:
- AstraZeneca
- Bristol-Myers Squibb
- Biocrates Life Sciences
- Eagle Genomics
- Eli Lilly And Company
- F. Hoffmann-La Roche AG
- Novartis
- Pfizer
- Quest Diagnostics
- Teva Pharmaceutical
Precision Medicine Market: Who Should Purchase, and How It Will Help Readers
- The report is best suited for top-level decision-makers, individuals who are supposed to take a leadership role or require market research to start a business, independent researchers, research institutes, and anyone who wishes to gain detailed strategic insights into the precision medicine market.
- This report provides a qualitative and quantitative analysis of the market segments, current trends, estimations, and dynamics of the precision medicine market analysis from 2018 to 2033 to identify the prevailing market opportunities.
- Market research and information related to key drivers, restraints, and opportunities are offered.
- Porter's five forces and PESTLE analysis highlight the potency of buyers and suppliers to enable stakeholders' market profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the precision medicine segmentation assists in determining the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional and global precision medicine industry trends, key players, market segments, application areas, and market growth strategies.
- The report offers insights from primary interviews and CXOs of major industry players. It also offers a comprehensive contact and event repository to ensure future collaborations among industry stakeholders.
Precision Medicine Market: Frequently Asked Questions (FAQ)
Q: How big is the precision medicine market?
A: The global Precision Medicine market showcased a revenue of USD 57.77 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 11% over the forecast period of 2023-2033.
Q: Does the report have several precision medicine numbers bifurcated by segments and regions?
A: The report offers a total number of precision medicine market , further bifurcated into segments and regions. Please refer to the TOC page for more information.
Q: What are the major trends in the precision medicine market?
A:Proliferation within the scope of application of Precision Medicine for non-communicable diseases, integration of AI and bioinformatics, and rising advancement towards Cancer biology and treatment are significant factors defining the market of Precision Medicine within the forecast period.
Q: How can I get the sample Report on the precision medicine market?
A: The precision medicine market report sample can be obtained on demand from the website. Also, 24*7 chat support and direct call services are provided to procure the sample report
Q: Is it possible to purchase a specific or customized report as per my needs
A: Yes, it is possible to purchase a specific part of the report or edit the scope of the report at your convenience. Feel free to drop us the mail/talk to our customer support or schedule a conversation to procure a customized report.
Report Coverage
- Delivery Type
- Application
- Administration
- End Use
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Increasing detection of cancer and other genetic diseases through advancement in medical technologies
- Rising applicability of precision medicines on non-communicable and less threatening diseases
- Lack of skilled labour and limited penetration at global level
AstraZeneca, Bristol-Myers Squibb, Biocrates Life Sciences, Eagle Genomics, Eli Lilly And Company, F. Hoffmann-La Roche AG, Novartis, Pfizer, Quest Diagnostics, and Teva Pharmaceutical.
1. Introduction
1.1 Report Description
1.1.1 Definition
1.1.2 Abbreviations
1.2 Key Market Segments
1.3 Benefits to Stakeholders
1.4 Research Methodology
1.4.1 Market Scoping
1.4.1.1 Problem Identification
1.4.1.2 Defining the Market
1.4.2 Market Estimation
1.4.2.1 Data Mining
1.4.2.2 Product Analysis
1.4.2.3 Application Analysis
1.4.2.4 Market Engineering and Forecasting
1.4.2.4.1 Bottom-up Demand Side
1.4.2.4.2 Bottom-up Supply side
1.4.3 Market Authentication
1.4.3.1 Data Triangulation
1.4.3.1.1 Top-down Supply Side
1.4.3.1.2 Top-down Demand Side
1.4.3.1.3 Data Triangulation
1.4.3.2 Primary Insights and Industry feedback
1.4.4 Report Writing
2. Executive Summary
2.1 Market Snapshot
2.2 Macro Trends, Global Economic Factors and Import/Export Insights
2.3 Primary Insights
2.4 Delivery Type Insights
2.5 Application Insights
2.6 Administration Insights
2.7 End Use Insights
2.8 Regional Insights
3. Market Overview
3.1 Market Segment and Scope
3.2 Top Investment Pockets
3.3 Key Strategic Initiatives
3.4 Precision Medicine Market Industry Ecosystem
3.5 Market Evolution
3.6 Patent Analysis
3.7 Technology Landscape
3.8 Regulatory Infrastructure
3.9 Porter’s Analysis
3.9.1 Bargaining Power of Buyer
3.9.2 Bargaining Power of Supplier
3.9.3 Threat of New Entrants
3.9.4 Threat of Substitutes
3.9.5 Industry Rivalry
3.10 PESTLE Analysis
3.11 Market Dynamics
3.11.1 Drivers
3.11.2 Restrains
3.11.3 Opportunities
3.12 Impact of COVID-19 on Precision Medicine Market
3.13 Russia-Ukraine War Impact on Precision Medicine Market
3.14 Growth Share Matrix
3.15 Precision Medicine Market Quadrant
4. Precision Medicine Market, By Delivery Type
4.1 Major Impacting Factors, By Delivery Type
4.1.1 Key Market Trends and Growth Factors
4.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.2 On Premise
4.2.1 Key Market Trends and Growth Factors
4.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3 Off Premise
4.3.1 Key Market Trends and Growth Factors
4.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5. Precision Medicine Market, By Application
5.1 Major Impacting Factors, By Application
5.1.1 Key Market Trends and Growth Factors
5.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.2 CNS
5.2.1 Key Market Trends and Growth Factors
5.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.3 Oncology
5.3.1 Key Market Trends and Growth Factors
5.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.4 Immunology
5.4.1 Key Market Trends and Growth Factors
5.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.5 Respiratory
5.5.1 Key Market Trends and Growth Factors
5.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.6 Rare Diseases
5.6.1 Key Market Trends and Growth Factors
5.6.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.6.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.7 Others
5.7.1 Key Market Trends and Growth Factors
5.7.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.7.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6. Precision Medicine Market, By Administration
6.1 Major Impacting Factors, By Administration
6.1.1 Key Market Trends and Growth Factors
6.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.2 Oral
6.2.1 Key Market Trends and Growth Factors
6.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.3 Injectable
6.3.1 Key Market Trends and Growth Factors
6.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7. Precision Medicine Market, By End Use
7.1 Major Impacting Factors, By End Use
7.1.1 Key Market Trends and Growth Factors
7.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.2 Healthcare Suppliers and Diagnostic Suppliers
7.2.1 Key Market Trends and Growth Factors
7.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.3 Academic Bodies and Research Centers
7.3.1 Key Market Trends and Growth Factors
7.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.4 Pahrma and Biotechnology Companies
7.4.1 Key Market Trends and Growth Factors
7.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.5 Others
7.5.1 Key Market Trends and Growth Factors
7.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8. Precision Medicine Market, By Region
8.1 Global Market Trends and Growth Factors
8.2 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.4 Market Size and Forecast, by Administration, 2018-2033, (USD Billion)
8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.6 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
8.7 North America
8.7.1 Key Market Trends and Growth Factors
8.7.2 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.4 Market Size and Forecast, by Administration, 2018-2033, (USD Billion)
8.7.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.7.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.7.7 U.S.
8.7.7.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.7.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.7.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.7.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.7.8 Canada
8.7.8.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.7.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.8.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.7.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.7.9 Mexico
8.7.9.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.7.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.9.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.7.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8 Europe
8.8.1 Key Market Trends and Growth Factors
8.8.2 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.4 Market Size and Forecast, by Administration, 2018-2033, (USD Billion)
8.8.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.8.7 UK
8.8.7.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.8.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.7.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.8.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.8 Germany
8.8.8.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.8.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.8.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.8.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.9 France
8.8.9.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.8.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.9.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.8.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.10 Russia
8.8.10.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.8.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.10.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.8.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.11 Italy
8.8.11.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.8.11.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.11.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.8.11.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.8.12 Rest of Europe
8.8.12.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.8.12.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.12.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.8.12.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9 Asia-Pacific
8.9.1 Key Market Trends and Growth Factors
8.9.2 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.4 Market Size and Forecast, by Administration, 2018-2033, (USD Billion)
8.9.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.9.7 China
8.9.7.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.9.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.7.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.9.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.8 India
8.9.8.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.9.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.8.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.9.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.9 Japan
8.9.9.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.9.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.9.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.9.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.10 Australia
8.9.10.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.9.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.10.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.9.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.9.11 Rest of Asia-Pacific
8.9.11.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.9.11.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.11.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.9.11.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10 Latin America
8.10.1 Key Market Trends and Growth Factors
8.10.2 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.4 Market Size and Forecast, by Administration, 2018-2033, (USD Billion)
8.10.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.10.7 Brazil
8.10.7.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.10.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.7.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.10.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.8 Argentina
8.10.8.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.10.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.8.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.10.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.9 Mexico
8.10.9.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.10.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.9.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.10.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.10.10 Chile
8.10.10.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.10.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.10.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.10.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11 Middle East and Africa
8.11.1 Key Market Trends and Growth Factors
8.11.2 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.11.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.4 Market Size and Forecast, by Administration, 2018-2033, (USD Billion)
8.11.5 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.11.7 South Africa
8.11.7.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.11.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.7.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.11.7.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.8 UAE
8.11.8.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.11.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.8.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.11.8.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.9 Saudi Arabia
8.11.9.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.11.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.9.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.11.9.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
8.11.10 Israel
8.11.10.1 Market Size and Forecast, by Delivery Type, 2018-2033, (USD Billion)
8.11.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.10.3 Market Size and Forecast, by Adminstration, 2018-2033, (USD Billion)
8.11.10.4 Market Size and Forecast, by End Use, 2018-2033, (USD Billion)
9. Competitive Benchmarking & Company Profiles
9.1 Competitive Benchmarking
9.1.1 Company Market Share
9.1.2 Product Mapping
9.1.3 Competitive Heat map
9.2 AstraZeneca
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Product Offering
9.2.4 Strategic Initiatives
9.2.5 SWOT
9.2.6 Ansoff Matrix
9.3 Bristol-Myers Squibb
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Product Offering
9.3.4 Strategic Initiatives
9.3.5 SWOT
9.3.6 Ansoff Matrix
9.4 Biocrates Life Sciences
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Product Offering
9.4.4 Strategic Initiatives
9.4.5 SWOT
9.4.6 Ansoff Matrix
9.5 Eagle Genomics
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Product Offering
9.5.4 Strategic Initiatives
9.5.5 SWOT
9.5.6 Ansoff Matrix
9.6 Eli Lilly And Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Product Offering
9.6.4 Strategic Initiatives
9.6.5 SWOT
9.6.6 Ansoff Matrix
9.7 F. Hoffmann-La Roche AG
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Product Offering
9.7.4 Strategic Initiatives
9.7.5 SWOT
9.7.6 Ansoff Matrix
9.8 Novartis
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Product Offering
9.8.4 Strategic Initiatives
9.8.5 SWOT
9.8.6 Ansoff Matrix
9.9 Pfizerr
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Product Offering
9.9.4 Strategic Initiatives
9.9.5 SWOT
9.9.6 Ansoff Matrix
9.10 Quest Diagnostics
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Product Offering
9.10.4 Strategic Initiatives
9.10.5 SWOT
9.10.6 Ansoff Matrix
9.11 Teva Pharmaceutical
9.11.1 Company Overview
9.11.2 Financial Analysis
9.11.3 Product Offering
9.11.4 Strategic Initiatives
9.11.5 SWOT
9.11.6 Ansoff Matrix
10. Industry Connects and Upcoming Seminars
